141 related articles for article (PubMed ID: 24801558)
1. Correlates of poor outcome among patients with bleeding after coronary interventions.
Ndrepepa G; Guerra E; Schulz S; Hoppmann P; Laugwitz KL; Kastrati A
Coron Artery Dis; 2014 Sep; 25(6):456-62. PubMed ID: 24801558
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
[TBL] [Abstract][Full Text] [Related]
3. Incidence and impact on prognosis of bleeding during percutaneous coronary interventions in patients with chronic kidney disease.
Ndrepepa G; Neumann FJ; Cassese S; Fusaro M; Ott I; Schulz S; Hoppmann P; Richardt G; Laugwitz KL; Schunkert H; Kastrati A
Clin Res Cardiol; 2014 Jan; 103(1):49-56. PubMed ID: 24092474
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age.
Ndrepepa G; Neumann FJ; Schulz S; Fusaro M; Cassese S; Byrne RA; Richardt G; Laugwitz KL; Kastrati A
Catheter Cardiovasc Interv; 2014 Feb; 83(2):182-9. PubMed ID: 24030753
[TBL] [Abstract][Full Text] [Related]
5. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
6. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
[TBL] [Abstract][Full Text] [Related]
7. Increased bleeding risk during percutaneous coronary interventions by arterial hypertension.
Ndrepepa G; Groha P; Lahmann AL; Lohaus R; Cassese S; Schulz-Schüpke S; Kufner S; Mayer K; Bernlochner I; Byrne RA; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
Catheter Cardiovasc Interv; 2016 Aug; 88(2):184-90. PubMed ID: 26526702
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
[TBL] [Abstract][Full Text] [Related]
9. Procedure-related bleeding in elective percutaneous coronary interventions.
Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
[TBL] [Abstract][Full Text] [Related]
10. Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
Farooq V; Serruys PW; Bourantas C; Vranckx P; Diletti R; Garcia Garcia HM; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; van Es GA; Steyerberg EW; Dawkins KD; Mohr FW; James S; Ståhle E
Eur Heart J; 2012 Dec; 33(24):3105-13. PubMed ID: 23103663
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
[TBL] [Abstract][Full Text] [Related]
12. Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).
Robertson JO; Ebrahimi R; Lansky AJ; Mehran R; Stone GW; Lincoff AM
JACC Cardiovasc Interv; 2014 Apr; 7(4):372-9. PubMed ID: 24630881
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.
Ndrepepa G; Schuster T; Hadamitzky M; Byrne RA; Mehilli J; Neumann FJ; Richardt G; Schulz S; Laugwitz KL; Massberg S; Schömig A; Kastrati A
Circulation; 2012 Mar; 125(11):1424-31. PubMed ID: 22344040
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
15. Frequency and impact of bleeding in elective coronary stent clinical trials--utility of three commonly used definitions.
Fleming LM; Novack V; Novack L; Cohen SA; Negoita M; Cutlip DE
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E23-9. PubMed ID: 22109802
[TBL] [Abstract][Full Text] [Related]
16. Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention.
Ndrepepa G; Keta D; Schulz S; Mehilli J; Birkmeier A; Neumann FJ; Schömig A; Kastrati A
Heart Vessels; 2010 Jul; 25(4):294-8. PubMed ID: 20676837
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of bleeding measured by Bleeding Academic Research Consortium (BARC) categorisation in patients undergoing primary percutaneous coronary intervention.
Matic DM; Milasinovic DG; Asanin MR; Mrdovic IB; Marinkovic JM; Kocev NI; Marjanovic MM; Antonijevic NM; Vukcevic VD; Savic LZ; Zivkovic MN; Mehmedbegovic ZH; Dedovic VM; Stankovic GR
Heart; 2014 Jan; 100(2):146-52. PubMed ID: 24179161
[TBL] [Abstract][Full Text] [Related]
18. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
19. Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy.
Ndrepepa G; Schulz S; Neumann FJ; Byrne RA; Hoppmann P; Cassese S; Ott I; Fusaro M; Ibrahim T; Tada T; Richardt G; Laugwitz KL; Schunkert H; Kastrati A
Am Heart J; 2013 Sep; 166(3):534-40. PubMed ID: 24016504
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
